Work

Brentuximab vedotin for relapsed or refractory non-Hodgkin lymphoma: Preliminary results from a phase II study.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8070

Authors: Ranjana Advani, Yasuhiro Oki, Andrei R. Shustov, Laurie E. Grove, Nancy Bartlett

Institutions: Stanford Medicine, The University of Texas MD Anderson Cancer Center, University of Washington Medical Center, Seagen (United States), Washington University in St. Louis

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2964980809

Cites:

Cited by: 5

Related to: 10